Inventiva (IVA) Research & Development (2019 - 2021)
Inventiva (IVA) posted quarterly Research & Development of -$14.3 million for Q2 2021, down 99.91% year-over-year from -$15.3 billion in Q2 2020, and down 65.27% quarter-over-quarter from -$8.7 million in Q1 2021.
Inventiva (IVA) Research & Development (2019 - 2021) Analysis & Trends
Inventiva's Research & Development history runs 3 years deep, the most recent figure standing at -$14.3 million for Q2 2021.
- In Q2 2021, Research & Development fell 99.91% year-over-year to -$14.3 million; the TTM figure through Jun 2021 stood at -$58.5 million (changed N/A YoY), while the FY2025 annual figure was $101.3 million, up 4.33% from the prior year.
- Research & Development for Q2 2021 stood at -$14.3 million, down from -$8.7 million in the prior quarter.
- The five-year high for Research & Development was -$6.7 million in Q1 2020, with the low at -$37.4 million in Q4 2019.
- The 3-year median for Research & Development is -$11.5 million (2021), against an average of -$17.1 million.
- The sharpest annual moves came in 2020 and 2021: Research & Development increased 24.4% in 2020, then tumbled 99.91% in 2021.
- Inventiva's Research & Development stood at -$37.4 million in 2019, then gained by 24.4% to -$28.3 million in 2020, then surged by 49.27% to -$14.3 million in 2021.
- Business Quant data shows IVA's Research & Development at -$14.3 million in Q2 2021, -$8.7 million in Q1 2021, and -$28.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -14.35 Mn |
| Mar 31, 2021 | -8.68 Mn |
| Dec 31, 2020 | -28.28 Mn |
| Jun 30, 2020 | -7.18 Mn |
| Mar 31, 2020 | -6.69 Mn |
| Dec 31, 2019 | -37.40 Mn |